about
negative regulation of oxidoreductase activitynegative regulation of metalloenzyme activitynegative regulation of hydrolase activitynegative regulation of transferase activitynegative regulation of lyase activitynegative regulation of ligase activitynegative regulation of catalytic activity in other organism involved in symbiotic interactionnegative regulation of histone demethylase activity (H3-K4 specific)negative regulation of cyclase activitynegative regulation of prostaglandin-E synthase activitycatabolite inactivation
P279
Prion proteinATPase, Cu++ transporting, alpha polypeptideInterleukin 7UDP glucuronosyltransferase 1 family, polypeptide A1Ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease)NestinSecretoglobin, family 1A, member 1 (uteroglobin)Annexin A2CD46 antigen, complement regulatory proteinAPOC2Predicted gene 44805CLN3 lysosomal/endosomal transmembrane protein, batteninMajor prion proteinPhosphodiesterase 6HEndosulfine alphaNitric oxide synthase interacting proteinAcidic nuclear phosphoprotein 32 family member ETIMP metallopeptidase inhibitor 1Cysteine rich transmembrane BMP regulator 1Amyloid beta precursor protein binding family A member 3TescalcinProtein phosphatase 1 regulatory subunit 12ACullin associated and neddylation dissociated 1Transmembrane BAX inhibitor motif containing 1NAD(P)H quinone dehydrogenase 1CAMP-dependent protein kinase inhibitor alphaSecretogranin VPutative annexin A2-like proteinPhosphodiesterase 6GFas associated factor family member 2Cell cycle and apoptosis regulator 2Folliculin interacting protein 2HSPA (Hsp70) binding protein 1Phosphoribosyl pyrophosphate synthetase associated protein 2Phosphoribosyl pyrophosphate synthetase associated protein 1MyoregulinPoly(ADP-ribose) polymerase family member 9Protein phosphatase 1 regulatory subunit 12BAnnexinThioredoxin interacting protein
P682
Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cellsTIP120A associates with cullins and modulates ubiquitin ligase activitySequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityUbiquitin is a novel substrate for human insulin-degrading enzyme
P921
Q14820940-A7FA03AD-FA8A-4C4F-B582-2387D8B64D82Q14884595-30691C4E-84A0-49B3-AEB0-D4E74C9F0D8AQ14910063-F2D77858-25B6-4520-A92E-E0C338853D05Q21101497-2EB953D0-4D61-4A4A-B2EA-BBBE0E9257AEQ21121933-632C8B6E-4612-47A7-B38E-12F196BDF5ABQ22244433-43489663-7098-45A8-BD86-2726B6AD7439Q22245628-D2583247-D32E-4A38-9D19-88FBBC2CCF30Q22245791-1D498990-BB4C-44F4-9C16-EB2AC95F7D10Q22299565-5C62606D-B0FB-4357-A666-C7EBB072C245Q22299664-9F03AAC7-C026-4B33-8E48-48FDE82C91C7Q69782528-a1e60470-4ff6-bf8e-6221-b1fc9b4921a0
P279
Q14881308-81772516-D157-4A82-8F7D-44DC04C62AD5Q14884615-C44B2E24-C5FC-4191-A55B-FE6BDA25E987Q14889534-901D887C-1DFF-40D9-A4C6-AAD9440A4CFAQ14901447-D9DAFD1E-061A-4B49-83CB-53FB67911CD0Q14905130-A97A8271-F1DE-49DA-93BA-2E6BA6009588Q14906820-94F3A5B8-A78B-4363-8EFA-EF81944E595FQ14907364-B04C5A13-7884-4AE4-A563-974766F9F842Q14908237-0E5E894E-C365-48DF-B762-152E4C39A98FQ14912095-0AEFB252-1B40-4A45-81F8-9A2A09BF421CQ14916272-5EEC06CA-1D43-4AD9-B485-7197EEFDA5F1Q14916274-7A6B2545-C550-4657-9F19-35DB1DC9210BQ1500005-C885869B-92EE-4455-BFA2-733CDDA55155Q21096129-CF49AAF2-D872-480D-9BA6-A3C93C199B3BQ21105644-7E869ECA-C657-4D62-8A2C-72412A336934Q21105880-D51B397A-B030-461D-94BE-AF59DA9B5123Q21109067-33213A96-9953-488C-BC8C-3E1680BE474CQ21109424-97C06960-296C-447E-9157-58E6E1D6CDF8Q21109683-F1DDEAE7-6432-43B4-AFA2-D9B5327A89D8Q21110788-90EB2179-BD9C-47D9-A187-47EFF99B69B0Q21111488-0984B2CA-3D59-451A-8EEC-9860C94923AFQ21111929-177F0EF0-DF4A-4B1E-B63B-4C3362CF194CQ21112088-339853F6-6AC3-4EFC-8420-1A5CC7AFCE8DQ21112922-C5950072-3F78-4847-8269-EE467A2D9305Q21113595-01C4B3AF-ACD7-4931-9D12-03163C69F412Q21114701-0BAC9A28-FFE1-49BF-9BE6-49104DE6F638Q21114729-004FD1EC-B438-456E-8A2E-309F26F8CC95Q21115115-AD917018-35F5-48CE-B872-FE95421DDCABQ21115367-1E9FFC75-AE00-4942-AED9-6FABB0DA16EBQ21115496-CD88FDFA-8FFE-4E79-AA17-CDDCE3231555Q21115888-E0D7E473-3313-4E1D-9939-12B20CC6A0C1Q21117052-C182ED00-0825-4E3E-A15C-AEAC2B6C5A00Q21118161-81C25632-636E-42E2-9F89-74818A3A766EQ21119131-07059D7D-62DE-46DB-B25B-1DA8AC28E190Q21119237-315A9BFB-267E-40FE-A5D5-3AEFD17B2218Q21119241-C8EABF1A-15BC-4805-98AB-32DB2014A422Q21120019-E3E2DCFD-5F5B-4022-9A14-5BFA9B7380A3Q21120400-AD5AB04A-F1F3-49CE-BA11-58F4F6AAE5D9Q21120891-11D76F49-1728-4B59-9BF9-895024EBF3A4Q21121822-85614DE7-88D3-4002-A7D7-D4F7CD88A91FQ21122281-CD44001A-A62E-45C6-8FD1-D5F5D1FA0177
P682
description
Any process that stops or reduces the activity of an enzyme.
@en
biologisch proces
@nl
name
negative regulation of catalytic activity
@en
negativno regulisanje katalitičke aktivnosti
@sr-el
негативно регулисање каталитичке активности
@sr
негативно регулисање каталитичке активности
@sr-ec
type
label
negative regulation of catalytic activity
@en
negativno regulisanje katalitičke aktivnosti
@sr-el
негативно регулисање каталитичке активности
@sr
негативно регулисање каталитичке активности
@sr-ec
altLabel
GO:0043086
@en
down regulation of enzyme activity
@en
down-regulation of enzyme activity
@en
down-regulation of metalloenzyme activity
@en
downregulation of enzyme activity
@en
negative regulation of enzyme activity
@en
prefLabel
negative regulation of catalytic activity
@en
negativno regulisanje katalitičke aktivnosti
@sr-el
негативно регулисање каталитичке активности
@sr
негативно регулисање каталитичке активности
@sr-ec
P2888
P686
GO:0043086